发明名称 |
LYOPHILIZED RECOMBINANT VWF FORMULATIONS |
摘要 |
PROBLEM TO BE SOLVED: To provide stable pharmaceutical formulations comprising recombinant von-Willebrand Factor (rVWF).SOLUTION: The present invention provides formulations useful for lyophilization of recombinant VWF, resulting in a highly stable pharmaceutical composition. The stable pharmaceutical composition is useful as a therapeutic agent in the treatment of individuals suffering from disorders or conditions that can benefit from the administration of recombinant VWF. In one embodiment, a stable lyophilized pharmaceutical formulation of recombinant rVWF is provided comprising: (a) a rVWF; (b) one or more buffering agents; (c) one or more amino acids; (d) one or more stabilizing agents; and (e) one or more surfactants.SELECTED DRAWING: None |
申请公布号 |
JP2016106124(A) |
申请公布日期 |
2016.06.16 |
申请号 |
JP20160035672 |
申请日期 |
2016.02.26 |
申请人 |
BAXTER INTERNATL INC;BAXTER HEALTHCARE SA |
发明人 |
KURT SCHNECKER;EVA HAIDWEGER;PETER TURECEK |
分类号 |
A61K38/43;A61K9/19;A61P7/04;A61P43/00 |
主分类号 |
A61K38/43 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|